Bone scintigraphy with99mtechnetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis
Authors:
- Andor W. J. M. GlaudemansAndor W. J. M. Glaudemans
- Ronald W. J. van RheenenRRRonald W. J. van Rheenen
- Maarten P. van Den BergMBMaarten P. van Den Berg
- Walter NoordzijWNWalter Noordzij
- Michel KooleMKMichel Koole
- Hans BlokzijlHBHans Blokzijl
- Rudi A. J. O. DierckxRDRudi A. J. O. Dierckx
- Riemer H. J. A. SlartRSRiemer H. J. A. Slart
- Bouke P. C. HazenbergBHBouke P. C. Hazenberg
- 14 November 2013
- journal article
- Published by Taylor & Francis in Amyloid
- Vol. 21 (1) , 35-44
Abstract
To assess the usefulness of bone scintigraphy with (99m)Technetium-hydroxymethylene diphosphonate ((99m)Tc-HDP) for the detection of cardiac involvement in a group of patients with ATTR amyloidosis in different phases of disease, to relate the findings to echocardiography, ECG and cardiac biomarkers, and to evaluate different bone scintigraphic techniques and calculation methods for quantification of the cardiac uptake and for correlation with echocardiographic features and cardiac biomarkers. Forty-one patients underwent clinical examinations, echocardiography, ECG, measurement of cardiac biomarkers and bone scintigraphy (planar imaging and SPECT-CT) and were subsequently subdivided into three groups: (1) carriers of an amyloidogenic TTR mutation, n = 11, (2) proven ATTR amyloidosis without echocardiographically-defined (mean wall thickness >12 mm) cardiac amyloidosis (AC), n = 19, and (3) ATTR amyloidosis with echocardiographically-defined cardiac amyloidosis, n = 11. Planar and SPECT-CT images were analyzed visually according to a routine scoring system (grade 0-3) and semi-quantitatively by heart-to-whole body (H/WB) and heart-to-skull (H/S) ratio on planar images and by a left ventricle-blood pool ratio on SPECT-CT images. All patients with ATTR and echocardiographically-defined AC and none of the carriers showed high cardiac uptake on bone scintigraphy. Furthermore, 8 out of 19 patients with ATTR without echocardiographically-defined AC showed high cardiac uptake. Highest correlations were found between H/S ratio on planar bone scintigraphy with troponin T (r = 0.76, p < 0.0001) and H/WB ratio with left ventricular mass index (r = 0.73, p < 0.0001). Bone scintigraphy with (99m)Tc-HDP may detect cardiac involvement in patients with ATTR amyloidosis prior to echocardiographic evidence of cardiac involvement. Cardiac uptake on bone scintigraphy correlates with severity of cardiac involvement using echocardiography, ECG and cardiac biomarkers. Visual grading and calculation of H/S ratio on planar imaging are the preferred methods to assess cardiac uptake.Keywords
This publication has 30 references indexed in Scilit:
- AmyloidosisRheumatic Disease Clinics of North America, 2013
- Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010
- Transthyretin-related amyloidoses and the heart: a clinical overviewNature Reviews Cardiology, 2010
- Amyloid Heart DiseaseProgress in Cardiovascular Diseases, 2010
- Systemic Cardiac AmyloidosesCirculation, 2009
- Differentiation of Hypertrophic Cardiomyopathy and Cardiac Amyloidosis from Other Causes of Ventricular Wall Thickening by Two-Dimensional Strain Imaging EchocardiographyThe American Journal of Cardiology, 2009
- Nuclear imaging in cardiac amyloidosisEuropean Journal of Nuclear Medicine and Molecular Imaging, 2009
- Biochemical characterisation of amyloid by endomyocardial biopsyAmyloid, 2009
- Pathogenesis of and Therapeutic Strategies to Ameliorate the Transthyretin AmyloidosesCurrent Pharmaceutical Design, 2008
- Evaluation and Management of the Cardiac AmyloidosisJACC, 2007